Geneoscopy is a healthcare diagnostics company using eukaryotic RNA biomarkers in stool samples
Location: United States, Missouri, Maryland Heights
Employees: 11-50
Total raised: $216.9M
Founded date: 2015
Investors 4
| Date | Name | Website |
| 10.01.2024 | Cultivatio... | cultivatio... |
| - | iSelect Fu... | iselectfun... |
| - | Lightchain... | lightchain... |
| - | Dorm Room ... | dormroomfu... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 10.01.2025 | Series C | $105M | - |
| 17.11.2021 | Series B | $105M | - |
| 02.10.2019 | Series A | $6.9M | - |
Mentions in press and media 11
| Date | Title | Description |
| 10.01.2025 | Geneoscopy: $105 Million (Series C) Raised For Developing Advanced Gastrointestinal Diagnostic Tests | Geneoscopy – a life sciences company focused on developing diagnostic tests for advancing gastrointestinal health – announced the closing of a Series C funding round raising $105 million. Bio-Rad Laboratories led the financing and was joine... |
| 09.01.2025 | Geneoscopy's Bold Leap: $105M Series C Funding Fuels Gastrointestinal Diagnostics Revolution | In the world of healthcare, innovation is the lifeblood. Geneoscopy, a St. Louis-based life sciences company, has just injected a hefty $105 million into its veins through a Series C funding round. This financial boost is not just a number;... |
| 08.01.2025 | Geneoscopy closes $105M in Series C funding round to power next-generation of gastrointestinal diagnostic tests | Bio-Rad leads investment to support the launch of ColoSense®, a non-invasive colorectal cancer screening test, and advance diagnostic innovations for inflammatory bowel disease ST. LOUIS & HERCULES, Calif. – Jan. 8, 2025 — Geneoscopy, I... |
| 08.01.2025 | Geneoscopy Closes $105M in Series C Funding | Geneoscopy, a St. Louis, MO-based life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, raised $105M in Series C funding. The round was led by Bio-Rad Laboratories (NYSE: BIO and BIO.B)... |
| 26.06.2024 | Envisioning a future where food is synonymous with health, fostering longevity, productivity, and societal well-being | If you missed Carter’s testimony at the Senate hearing, “Feeding a Healthier America: Current Efforts and Potential Opportunities for Food is Medicine,” the replay is available here. The hearing emphasized the importance of nutrition to red... |
| 17.11.2021 | Geneoscopy Closes $105M in Series B Funding | Geneoscopy, a ST Louis, MO-based life sciences company focused on development of diagnostic tests for gastrointestinal health, raised $105M in Series B funding. The round was led by Lightchain Capital and NT Investments with participation f... |
| 17.03.2021 | Geneoscopy Appoints Don Hardison to its Strategic Advisory Board | ST. LOUIS--(BUSINESS WIRE)--Mar 17, 2021-- Geneoscopy Inc., a life sciences company that develops diagnostic tests for gastrointestinal health, today announced the appointment of Don Hardison to the Company’s strategic advisory board. Don b... |
| 03.03.2021 | Geneoscopy Appoints Vince Wong as Chief Commercial Officer | ST. LOUIS--(BUSINESS WIRE)--Mar 3, 2021-- Geneoscopy Inc., a life sciences company that develops diagnostic tests for gastrointestinal health, today announced the appointment of Vince Wong as Chief Commercial Officer. Mr. Wong brings almost... |
| 02.10.2019 | Geneoscopy Raises $6.9M in Series A | ST. LOUIS, MO, Life sciences company focused on the development of diagnostic tests for gastrointestinal (GI) health, has raised a $6.9M Series A financing. >> Click here for more funding data on Geneoscopy >> To export Gene... |
| 02.10.2019 | Geneoscopy Raises $6.9M in Series A Funding | Geneoscopy, Inc., a St. Louis-based life sciences company focused on the development of diagnostic tests for gastrointestinal (GI) health, raised $6.9m in Series A financing. The round was was led by Cultivation Capital and NT Investments, ... |
Show more